Human AAT has been used for the treatment of alpha 1 antitrypsin deficiency (AATD) and tested for the treatment of other diseases including type 1 diabetes [22,27,28,29,44], arthritis [30,31], and GVHD [45]. This evidence concerns the gene SERPINA1 and Alpha-1-antitrypsin deficiency.